|
| |

ProArc Medical Ltd. is an early-stage medical device start-up dedicated to developing innovative, minimally invasive, and clinically effective devices for the field of urology.
The Company’s first product, ClearRing™, is designed to treat lower urinary tract symptoms due to benign prostatic hyperplasia (BPH), or enlarged prostate. www.proarcmedical.com |
|
|
|
|
|
| |

Serpin Pharma is a privately held biotech company developing a family of first-in-class anti-inflammatory and immune-modulating peptide drugs derived from human alpha-1 antitrypsin. The peptide drugs have broad applications in inflammatory and autoimmune diseases and represent a superior alternative to current alpha-1 antitrypsin for select indications. Serpin’s research facilities are located in northern Virginia (United States). www.serpinpharma.com |
|
|
|
|
|
| |

Tubular Medical Ltd. is taking an innovative approach to reduce the bioburden (number of bacteria present on a surface before sterilization) in patients with an endotracheal (ET) tube. Although an ET tube is vital for safe and effective ventilation, currently available tubes present a significant drawback: Secretions, biofilms, and aerosolized medications that accumulate on the inner surface may cause increased airway resistance, acute tube obstruction, delayed weaning, and Ventilator Associated Pneumonia (VAP). Tubular Medical introduces a proprietary, fully “peelable” inner surface technology for a simple and highly effective solution to accumulation in ET tubes. tubularmedical.wix.com/home |
|
|
|
|
|
| |

Speech synthesis solutions (translating written text into spoken text) have yet to achieve a level that makes them indistinguishable from human speech.VivoText’s text-to-speech (TTS) engine delivers speech synthesis that is virtually indistinguishable from “real” human voices.
The engine is modeled after a proven technology called Music Objects Recognition (MOR), which was developed by VivoText’s founder.
vivotext.com |
|
|
|
|
|
|
|
|